Anti-inflammatory drugs can cut risk of heart attacks: Study

Anti-inflammatory drugs can cut risk of heart attacks: Study

A new study by a team of health experts from Brigham & Women’s Hospital has suggested that anti-inflammatory drugs can significantly slash the risk of heart attacks and strokes.

The team examined nearly 10,000 patients and found that the anti-inflammatory drug canakinumab was able to reduce the risk of a repeated heart attack among patients by 15 per cent.

Dr. Paul M. Ridker, the director of the Center for Cardiovascular Disease Prevention at Brigham & Women’s Hospital, said that the finding represented the end game of decades of research, stemming from a critical observation that 50 per cent of heart attacks hit people who don’t have high cholesterol.

Speaking on the topic, Ridker said, “For the first time, we’ve been able to definitively show that lowering inflammation independent of cholesterol reduces cardiovascular risk. This has far-reaching implications.”

The study suggested that by leveraging this new way to treat patients, targeting inflammation, it is possible to significantly improve results for certain very high-risk populations.

The findings were presented at the European Society of Cardiology meeting and published in the most recent edition of the New England Journal of Medicine.